《歐洲經濟》歐元區7月工業生產按月回升1.5% 勝預期
歐盟統計局公佈,經季節調整後,歐元區今年7月工業生產按月回升1.5%(前值降0.1%),結束連降兩個月,也優於市場預期升0.6%;按年升幅繼續放緩至7.7%(前值升10.1%),高於市場預期升6%,且已連升5個月。
期內,資本貨物產出按月升2.7%(前值跌1.1%);按年升幅繼續收窄至5.9%(前值升6.9%)。能源產出按月降幅略擴至0.6%,且已連跌三個月;按年升幅繼續收窄至1%(前值升3.4%)。中間產品產出按月升幅擴至0.4%(前值升0.2%);按年升幅繼續收窄至11.2%(前值升15.9%)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.